DAWLEY MEDICAL PRACTICE — All Prescriptions & Medications — Page 4
Practice Code: M82009 | TELFORD, TF4 2AA
Showing results 151-200 of 653
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Trimethoprim | 308 | 10.6K | £497 | +50.7% ▲ |
| 307 | 40.8K | £2.2K | -35.3% ▼ | |
| Risedronate sodium | 306 | 1,340 | £365 | +152.3% ▲ |
| Hydroxychloroquine sulfate | 302 | 10.8K | £501 | +56.0% ▲ |
| Clobetasone butyrate | 300 | 18.2K | £1.7K | +47.0% ▲ |
| Hydroxyzine hydrochloride | 297 | 15.5K | £462 | +457.5% ▲ |
| Tiotropium bromide | 294 | 4,760 | £9.8K | -3.3% ▼ |
| Fluticasone propionate (Inhalation) | 292 | 399 | £7.7K | -24.5% ▼ |
| Vortioxetine | 290 | 9,044 | £8.5K | +317.8% ▲ |
| Nicorandil | 283 | 16.7K | £2.6K | +96.6% ▲ |
| Bempedoic acid/Ezetimibe | 281 | 9,340 | £17.6K | +360.2% ▲ |
| Formoterol/glycopyrronium/budesonide | 281 | 294 | £12.4K | +366.6% ▲ |
| 281 | 2,883 | £5.2K | +915.6% ▲ | |
| Edoxaban | 276 | 9,193 | £15.3K | -60.6% ▼ |
| Co-careldopa (Carbidopa/levodopa) | 273 | 33.8K | £2.7K | +20.8% ▲ |
| Biphasic insulin aspart | 273 | 1,838 | £11.0K | +168.9% ▲ |
| Lercanidipine hydrochloride | 259 | 11.0K | £1.2K | -58.1% ▼ |
| Buprenorphine | 243 | 1,068 | £4.7K | -33.7% ▼ |
| Cyclizine hydrochloride | 237 | 14.2K | £497 | +46.9% ▲ |
| Tolterodine | 236 | 8,792 | £1.5K | +58.7% ▲ |
| Calcipotriol | 231 | 21.9K | £13.0K | +35.7% ▲ |
| Aripiprazole | 230 | 8,752 | £1.6K | -9.6% ▼ |
| Paroxetine hydrochloride | 230 | 6,448 | £408 | +23.3% ▲ |
| 230 | 44.9K | £2.2K | +126.4% ▲ | |
| Sacubitril/valsartan | 225 | 13.7K | £22.4K | -6.0% ▼ |
| 224 | 2,812 | £6.7K | +469.4% ▲ | |
| Lymecycline | 223 | 9,800 | £1.2K | +85.4% ▲ |
| Lisdexamfetamine dimesylate | 221 | 6,196 | £15.6K | +85.1% ▲ |
| 220 | 5,071 | £1.2K | +559.2% ▲ | |
| Metronidazole | 215 | 5,379 | £1.1K | +227.2% ▲ |
| Timolol and bimatoprost | 214 | 3,507 | £3.8K | +41.0% ▲ |
| Nebivolol | 213 | 7,660 | £1.2K | +100.9% ▲ |
| Chlorphenamine maleate | 211 | 24.5K | £690 | +91.2% ▲ |
| Linagliptin | 211 | 6,553 | £7.4K | -48.5% ▼ |
| Nifedipine | 207 | 11.9K | £2.4K | +10.5% ▲ |
| Mometasone furoate | 207 | 11.9K | £1.1K | +54.8% ▲ |
| Clarithromycin | 204 | 5,946 | £977 | -16.9% ▼ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 204 | 219 | £3.1K | +79.9% ▲ |
| Mesalazine (Systemic) | 203 | 23.6K | £11.6K | -15.3% ▼ |
| Eplerenone | 203 | 6,090 | £762 | -23.4% ▼ |
| Tadalafil | 203 | 3,080 | £757 | +19.4% ▲ |
| Methylphenidate hydrochloride | 199 | 9,960 | £8.1K | -22.9% ▼ |
| Zolpidem tartrate | 197 | 5,614 | £249 | +118.6% ▲ |
| Hypromellose | 196 | 2,380 | £358 | +47.9% ▲ |
| Nystatin | 192 | 6,240 | £358 | +90.5% ▲ |
| Medroxyprogesterone acetate | 192 | 203 | £1.2K | +59.0% ▲ |
| 192 | 5,072 | £5.3K | +417.2% ▲ | |
| Topiramate | 191 | 13.0K | £1.2K | +7.5% ▲ |
| Fluticasone furoate | 191 | 209 | £1.4K | -1.4% vs avg |
| Nortriptyline | 188 | 14.1K | £457 | +29.2% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.